Matrix Metalloproteinase 1 Is Necessary for the Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Human Glioma

Abstract

Human mesenchymal stem cells (MSCs) have increasingly been used as cellular vectors for the delivery of therapeutic genes to tumors. However, the precise mechanism of mobilization remains poorly defined. In this study, MSCs that expressed similar cell surface markers and exhibited multilineage differentiation potentials were isolated from various donors. Interestingly, different MSC isolates displayed differential migration ability toward human glioma cells. We hypothesized that distinct molecular signals may be involved in the varied tumor tropisms exhibited by different MSC isolates. To test this hypothesis, gene expression profiles of tumor-trophic MSCs were compared with those of non–tumor-trophic MSCs. Among the various differentially regulated genes, matrix metalloproteinase one (MMP1) gene expression and its protein activities were enhanced by 27-fold and 21-fold, respectively, in highly migrating MSCs compared with poorly migrating MSCs. By contrast, there was no change in the transcriptional levels of other MMPs. Functional inactivation of MMP1 abrogated the migratory potential of MSCs toward glioma-conditioned medium. Conversely, the nonmigratory phenotype of poorly migrating MSC could be rescued in the presence of either recombinant MMP1 or conditioned medium from the highly migrating MSCs. Ectopic expression of MMP1 in these poorly migrating cells also rendered the cells responsive to the signaling cues from the glioma cells in vivo. However, blocking the interaction of MMP1 and its cognate receptor PAR1 effectively diminished the migratory ability of MSCs. Taken together, this study provides, for the first time, supporting evidence that MMP1 is critically involved in the migration capacity of MSCs, acting through the MMP1/PAR1 axis. Disclosure of potential conflicts of interest is found at the end of this article.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 36

1. 1.

   Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845-848.

   Not in our library10.1126/science.283.5403.845

2. 2.

   Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006;34:967-975.

   Not in our library10.1016/j.exphem.2006.04.002

3. 3.

   Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201:1307-1318.

   Not in our library10.1084/jem.20041385

4. 4.

   Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615-1622.

   Not in our library10.1161/01.cir.0000124476.32871.e3

5. 5.

   Ip JE, Wu Y, Huang J, et al. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007;18:2873-2882.

   Not in our library10.1091/mbc.e07-02-0166

6. 6.

   Kahn J, Byk T, Jansson-Sjostrand L, et al. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood. 2004;103:2942-2949.

   Not in our library10.1182/blood-2003-07-2607

7. 7.

   Shi M, Li J, Liao L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica. 2007;92:897-904.

   Not in our library10.3324/haematol.10669

8. 8.

   Kyriakou C, Rabin N, Pizzey A, et al. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica. 2008;93:1457-1465.

   Not in our library10.3324/haematol.12553

9. 9.

   Chen X, Li Y, Wang L, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology. 2002;22:275-279.

   Not in our library10.1046/j.1440-1789.2002.00450.x

10. 10.

    Neuss S, Becher E, Woltje M, et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells. 2004;22:405-414.

    Not in our library10.1634/stemcells.22-3-405

11. 11.

    Schmidt A, Ladage D, Schinkothe T, et al. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006;24:1750-1758.

    Not in our library10.1634/stemcells.2005-0191

12. 12.

    Okuyama H, Krishnamachary B, Zhou YF, et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem. 2006;281:15554-15563.

    Not in our library10.1074/jbc.m602003200

13. 13.

    Gutova M, Najbauer J, Frank RT, et al. uPA and uPAR mediate human stem cell tropism to malignant solid tumors. Stem Cells. 2008;26:1406-1413.

    Not in our library10.1634/stemcells.2008-0141

14. 14.

    Mehlen P, Puisieux A. Metastasis: A question of life or death. Nat Rev Cancer. 2006;6:449-458.

    Not in our library10.1038/nrc1886

15. 15.

    Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000;6:391-407.

    Not in our library

16. 16.

    Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.

    Not in our library10.1146/annurev.cellbio.17.1.463

17. 17.

    Pei D. Matrix metalloproteinases target protease-activated receptors on the tumor cell surface. Cancer Cell. 2005;7:207-208.

    Not in our library10.1016/j.ccr.2005.02.011

18. 18.

    Boire A, Covic L, Agarwal A, et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 2005;120:303-313.

    Not in our library10.1016/j.cell.2004.12.018

19. 19.

    Ho IA, Chan KY, Miao L, et al. HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells. Cancer Gene Ther. 2008;15:553-562.

    Not in our library10.1038/cgt.2008.27

20. 20.

    Varani J, Orr W, Ward PA. A comparison of the migration patterns of normal and malignant cells in two assay systems. Am J Pathol. 1978;90:159-171.

    Not in our library

21. 21.

    Ho IA, Hui KM, Lam PY. Targeting proliferating tumor cells via the transcriptional control of therapeutic genes. Cancer Gene Ther. 2006;13:44-52.

    Not in our library10.1038/sj.cgt.7700864

22. 22.

    Ries C, Egea V, Karow M, et al. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines. Blood. 2007;109:4055-4063.

    Not in our library10.1182/blood-2006-10-051060

23. 23.

    De Becker A, Van Hummelen P, Bakkus M, et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica. 2007;92:440-449.

    Not in our library10.3324/haematol.10475

24. 24.

    Kalwitz G, Endres M, Neumann K, et al. Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol. 2009;41:649-658.

    Not in our library10.1016/j.biocel.2008.07.011

25. 25.

    Menon LG, Picinich S, Koneru R, et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells. 2007;25:520-528.

    Not in our library10.1634/stemcells.2006-0257

26. 26.

    Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature. 1994;370:555-557.

    Not in our library10.1038/370555a0

27. 27.

    Hashimoto G, Inoki I, Fujii Y, et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem. 2002;277:36288-36295.

    Not in our library10.1074/jbc.m201674200

28. 28.

    Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol. 1995;7:728-735.

    Not in our library10.1016/0955-0674(95)80116-2

29. 29.

    Miyazaki K, Hattori Y, Umenishi F, et al. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res. 1990;50:7758-7764.

    Not in our library

30. 30.

    Rorive S, Berton A, D'Haene N, et al. Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas. Glia. 2008;56:1679-1690.

    Not in our library10.1002/glia.20719

31. 31.

    Ozaki Y, Nishimura M, Sekiya K, et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev. 2007;16:119-129.

    Not in our library10.1089/scd.2006.0032

32. 32.

    Shi X, Gangadharan B, Brass LF, et al. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res. 2004;2:395-402.

    Not in our library

33. 33.

    Lin JL, Wang MJ, Lee D, et al. Hypoxia-inducible factor-1alpha regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells. FEBS Lett. 2008;582:2615-2619.

    Not in our library10.1016/j.febslet.2008.06.033

34. 34.

    Partridge CR, Hawker JR, Forough R. Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J Cell Biochem. 2000;78:487-499.

    Not in our library

35. 35.

    Smadja DM, Bieche I, Uzan G, et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol. 2005;25:2321-2327.

    Not in our library10.1161/01.atv.0000184762.63888.bd

36. 36.

    Wynn RF, Hart CA, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104:2643-2645.

    Not in our library10.1182/blood-2004-02-0526

Cited by papers we hold 2

• Effects of matrix metalloproteinases on the fate of mesenchymal stem cells · 2016
  No notice
• The roles of mesenchymal stem cells in tumor inflammatory microenvironment · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.